Page results
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
A team of clinicians and researchers at UCLH and UCL have been awarded a £2.8 million grant to combat health inequalities in patients having major surgery.
-
Information for patients from overseas visiting UCLH hospitals.
-
Today is International Clinical Trials Day, an important day on the UCLH calendar because research is an integral part of UCLH’s mission.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
File results
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics